+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Flexible implementations of group sequential stopping rules using constrained boundaries



Flexible implementations of group sequential stopping rules using constrained boundaries



Biometrics 59(4): 770-777



Group sequential stopping rules are often used during the conduct of clinical trials in order to attain more ethical treatment of patients and to better address efficiency concerns. Because the use of such stopping rules materially affects the frequentist operating characteristics of the hypothesis test, it is necessary to choose an appropriate stopping rule during the planning of the study. It is often the case, however, that the number and timing of interim analyses are not precisely known at the time of trial design, and thus the implementation of a particular stopping rule must allow for flexible determination of the schedule of interim analyses. In this article, we consider the use of constrained stopping boundaries in the implementation of stopping rules. We compare this approach when used on various scales for the test statistic. When implemented on the scale of boundary crossing probabilities, this approach is identical to the error spending function approach of Lan and DeMets (1983).

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049091179

Download citation: RISBibTeXText

PMID: 14969454


Related references

Flexible Implementations of Group Sequential Stopping Rules Using Constrained Boundaries. Biometrics 59(4): 0-7, 2003

The application of group sequential stopping boundaries to evaluate the treatment effect of an experimental agent across a range of biomarker expression. Contemporary Clinical Trials 63: 13-18, 2017

Sequential Stopping Rules for Species Accumulation. Journal of Agricultural, Biological, and Environmental Statistics 8(2): 184-195, 2003

Sequential stopping rules for species accumulation. Journal of Agricultural Biological and Environmental Statistics e; 8(2): 184-195, 2003

Sequential stopping rules in clinical trials. Statistics in Medicine 9(6): 595-600, 1990

Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses. Journal of Biopharmaceutical Statistics 24(4): 817-833, 2015

Comparison of some sequential procedures with related optimal stopping rules. Probability Theory and Related Fields 70(3): 411-416, 1985

Sequential stopping rules and sequentially adjusted P values: does one require the other?. Controlled Clinical Trials 4(1): 3-10, 1983

Rejoinder: statistical inference from trials with sequential stopping rules. Controlled Clinical Trials 4(1): 27-33, 1983

One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach. Biometrics 44(1): 219-227, 1988

One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach. Biometrics 44(1): 219-227, 1988

On the frequentist and likelihood controversy over sequential stopping rules in clinical trials. Controlled Clinical Trials 4(3): 261-263, 1983

Early stopping rules in clinical trials based on sequential monitoring of serious adverse events. Medical Decision Making 29(3): 343-350, 2009

Issues in designing sequential stopping rules for monitoring side effects in clinical trials. Controlled Clinical Trials 8(4): 327-337, 1987

Software to compute and conduct sequential Bayesian phase I or II dose-ranging clinical trials with stopping rules. Computer Methods and Programs in Biomedicine 72(2): 117-125, 2003